Sun Pharmaceuticals - Double top - Exhausted uptrend

is forming a potential double-top structure near the ₹1,950–1,990 resistance zone, with the recent rejection keeping the setup cautious. The neckline/support zone is around ₹1,880; a decisive break below this level would confirm the pattern and could open downside toward ₹1,830–1,800. As long as ₹1,880 holds, the broader uptrend remains intact and the stock can attempt another move toward ₹1,990. A sustained breakout above ₹1,990 would invalidate the double-top setup and signal fresh upside momentum.